My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 918

    1.

    Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.

    Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS.

    Diabetes. 2007 Feb;56(2):337-45. Erratum in: Diabetes. 2007 May;56(5):1486. PMID: 17259377 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB.

    Zheng L, Szabó C, Kern TS.

    Diabetes. 2004 Nov;53(11):2960-7.PMID: 15504977 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.

    Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP.

    Diabetes. 2007 Feb;56(2):373-9.PMID: 17259381 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants.

    Kowluru RA, Odenbach S.

    Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4161-6.PMID: 15505070 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.

    Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Döhmen S, Adamis AP.

    FASEB J. 2002 Mar;16(3):438-40. Epub 2002 Jan 30.PMID: 11821258 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants.

    Kowluru RA, Koppolu P, Chakrabarti S, Chen S.

    Free Radic Res. 2003 Nov;37(11):1169-80.PMID: 14703729 [PubMed - indexed for MEDLINE]Related articles

    7.

    Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.

    Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S.

    Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4342-50.PMID: 17724226 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Nuclear factor-kappaB p65 and upregulation of interleukin-6 in retinal ischemia/reperfusion injury in rats.

    Wang J, Jiang S, Kwong JM, Sanchez RN, Sadun AA, Lam TT.

    Brain Res. 2006 Apr 7;1081(1):211-8. Epub 2006 Mar 10.PMID: 16530172 [PubMed - indexed for MEDLINE]Related articles

    9.

    Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Müller cells: model of diabetic retinopathy.

    Shelton MD, Kern TS, Mieyal JJ.

    J Biol Chem. 2007 Apr 27;282(17):12467-74. Epub 2007 Feb 26.PMID: 17324929 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats.

    Du Y, Sarthy VP, Kern TS.

    Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R735-41.PMID: 15371279 [PubMed - indexed for MEDLINE]Related articles

    11.

    Inhibition of nuclear factor kappa B subunit p65 mRNA accumulation in lipopolysaccharide-stimulated human monocytic cells treated with sodium salicylate.

    Takashiba S, Van Dyke TE, Amar S.

    Oral Microbiol Immunol. 1996 Dec;11(6):420-4.PMID: 9467376 [PubMed - indexed for MEDLINE]Related articles

    12.

    Nuclear factor-kappa B p65 in NMDA-induced retinal neurotoxicity.

    Kitaoka Y, Kumai T, Kitaoka Y, Lam TT, Munemasa Y, Isenoumi K, Motoki M, Kuribayashi K, Kogo J, Kobayashi S, Ueno S.

    Brain Res Mol Brain Res. 2004 Nov 24;131(1-2):8-16.PMID: 15530647 [PubMed - indexed for MEDLINE]Related articles

    13.

    Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration.

    Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T.

    J Immunol. 1996 May 15;156(10):3961-9.PMID: 8621937 [PubMed - indexed for MEDLINE]Related articles

    14.

    Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.

    Fernández de Arriba A, Cavalcanti F, Miralles A, Bayón Y, Alonso A, Merlos M, García-Rafanell J, Forn J.

    Mol Pharmacol. 1999 Apr;55(4):753-60.PMID: 10101034 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects.

    Sun W, Gerhardinger C, Dagher Z, Hoehn T, Lorenzi M.

    Diabetes. 2005 Dec;54(12):3418-26.PMID: 16306357 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats.

    Kowluru RA, Odenbach S.

    Diabetes. 2004 Dec;53(12):3233-8.PMID: 15561955 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes.

    Zheng L, Gong B, Hatala DA, Kern TS.

    Invest Ophthalmol Vis Sci. 2007 Jan;48(1):361-7.PMID: 17197555 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Hyperglycemia increases mitochondrial superoxide in retina and retinal cells.

    Du Y, Miller CM, Kern TS.

    Free Radic Biol Med. 2003 Dec 1;35(11):1491-9.PMID: 14642397 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.

    Kern TS, Engerman RL.

    Diabetes. 2001 Jul;50(7):1636-42.PMID: 11423486 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.

    Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.

    Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3972-8.PMID: 11053301 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity